Antibe Therapeutics Inc. announced that Jonathan Ross Goodman has resigned from the company's Board of Directors, effective February 28, 2015.
Antibe Therapeutics Inc.
Equities
ATE
CA0370255097
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+16.60% | 124B | |
+17.07% | 109B | |
-7.24% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-6.56% | 16.61B | |
-37.63% | 16.43B | |
+1.59% | 13.4B | |
+23.61% | 11.47B |